Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Eiger BioPharmaceuticals, Inc. (EIGR)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
03/25/2022
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/06/2020
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/18/2019
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/17/2019
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/23/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/22/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/25/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/23/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/30/2017
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/26/2017
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
01/17/2017
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
08/19/2016
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
08/17/2016
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy